Clinical Trial

The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma

Name: The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma — clinical trial record (NCT05741359)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a multi-center, single-arm, open-label clinical study, and the sample size is set to 12-18 subjects.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2023-02-14; most recent amendment 2025-11-20.

Status change: Not Yet Recruiting → Recruiting 2024-01-04

Trial Details

NCT Number	NCT05741359
Lead Sponsor	Bioray Laboratories Collaborators: Chinese Academy of Medical Sciences, Zhejiang University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions	Non-hodgkin Lymphoma,B Cell
Enrollment	18 participants
Start Date	2023-04-25
Primary Completion	2026-11-20 (estimated)
Study Completion	2027-01-15 (estimated)
Updated on ClinicalTrials.gov	2025-11-25